Susan Abu-Absi
CIK: 0002148701
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AURA
Aura Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Abu-Absi Susan
Abu-Absi Susan (SEC CIK 0002148701) files insider reports with the SEC as Chief Operating Officer of Aura Biosciences, Inc. (AURA).
Signal8 holds 2 ownership filings by Abu-Absi Susan (1 Form 3, 1 Form 4), filed between Aug 12, 2026 and Sep 1, 2026. Those filings report 1 transaction, the latest on Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Abu-Absi Susan's filings is in BOSTON, MA.
Recent filings by Abu-Absi Susan
- Sep 1, 2026: Grant or award of AURA shares (Form 4, code A).
Other insiders filing for Aura Biosciences, Inc. (AURA)
- Person Julie, Chief People Officer
- Kratz Erica, Chief Reg. & Quality Officer
- Hopkins Janet Jill, Chief Medical Officer
- Elazzouzi Amy, SVP, Finance & PAO
- Bender Jeremy, Director
- Kilroy Conor